Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: Role of IgA in HIV-1 Protection |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2012-07-13 |
| Study Made Public: | 2016-01-15 |
Title
QC of IgA antibodies from RV144 vaccine recipient clonal memory B cell cultures
Description
CAVD 375 is an immunogenicity study to isolate and evaluate IgA antibodies using specimens from vaccine recipients in the human clinical trial, RV144.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.